Advertisement
Screener

Genpact Limited (G) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum

Genpact Limited Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum

Genpact Limited (G) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 1.37% for the 12-month period ending 2021-12-31, per its 10-K filed 2024-02-29.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2024-02-29

  • Genpact Limited share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2021 was 1.37%.
  • Genpact Limited share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2019 was 2.63%, a 10.24% decline from fiscal 2018.
  • Genpact Limited share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2018 was 2.93%.
  • Genpact Limited share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2016 was 1.56%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month
2021-12-311.37%
10-K · filed 2024-02-29
2019-12-312.63%
10-K · filed 2022-03-01
2019-09-302.63%
10-Q · filed 2019-11-08
2018-12-312.93%
10-K · filed 2021-03-01
2018-09-302.93%
10-Q · filed 2019-11-08
2018-06-302.93%
10-Q · filed 2019-08-09
2016-12-311.56%
10-K · filed 2019-03-01
2016-09-301.56%
10-Q · filed 2017-11-09
2014-12-312.29%
10-K · filed 2017-03-01
2014-09-302.29%
10-Q · filed 2015-11-06
2011-12-312.26%
10-K · filed 2012-02-29
2010-12-313.16%
10-K · filed 2013-03-01
2009-12-313.39%
10-K · filed 2012-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
FTI CONSULTING, INC (FCN)United States$3.602B16.33
EXPONENT INC (EXPO)United States$3.065B26.46
Huron Consulting Group Inc. (HURN)United States$2.557B20.80
Booz Allen Hamilton Holding Corp (BAH)United States$8.878B9.38
Astrana Health, Inc. (ASTH)United States$1.921B63.77
ICF International, Inc. (ICFI)United States$1.490B14.74
Bowman Consulting Group Ltd. (BWMN)United States$0.738B68.09
Onterris, Inc. (ONT)United States$0.590B-63.69
Public Policy Holding Company, Inc. (PPHC)United States$0.347B
Aeries Technology, Inc. (AERT)Cayman Islands$0.336B-0.00